trifluoperazine has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, E | 1 |
| Gorski, JP | 1 |
| Penniston, JT | 1 |
| Azzarone, B | 1 |
| Krief, P | 1 |
| Soria, J | 1 |
| Boucheix, C | 1 |
2 other studies available for trifluoperazine and Osteogenic Sarcoma
| Article | Year |
|---|---|
High-affinity Ca2+-stimulated and Mg2+-dependent ATPase from rat osteosarcoma plasma membranes.
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Calmodulin; Cell Membrane; Egtazic Acid | 1983 |
Modulation of fibroblast-induced clot retraction by calcium channel blocking drugs and the monoclonal antibody ALB6.
Topics: Animals; Antibodies, Monoclonal; Calcium Channel Blockers; Calmodulin; Cell Line; Clot Retraction; F | 1985 |